Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
País como asunto
Tipo del documento
Publication year range
1.
J Law Med ; 29(1): 208-223, 2022 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-35362289

RESUMEN

Biosimilar medicines have the potential to increase medicine access and bring cost savings to consumers, but uptake has been slow for a range of reasons. This article analyses one such reason, namely the potential for competitors' promotional materials to use certain terms with technical meanings, such as "interchangeable" and "substitution", in a misleading way. Against the backdrop of a flawed co-regulatory system for pharmaceutical marketing, the article identifies a need for clear regulatory statements about appropriate uses of such terms in pharmaceutical marketing and promotion.


Asunto(s)
Biosimilares Farmacéuticos , Mercadotecnía , Boca , Plásticos
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda